Journal of Leukocyte Biology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tyagi, S.
Right arrow Articles by Nicholson-Weller, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tyagi, S.
Right arrow Articles by Nicholson-Weller, A.
(Journal of Leukocyte Biology. 2000;68:679-686.)
© 2000 by Society for Leukocyte Biology

C5a-stimulated human neutrophils use a subset of ß2 integrins to support the adhesion-dependent phase of superoxide production

ShivRaj Tyagi*,{dagger}, Lloyd B. Klickstein{dagger},{ddagger} and Anne Nicholson-Weller*,{dagger}

* Divisions of Infectious Diseases and Allergy and Inflammation, Department of Medicine, and Charles A. Dana Research Institute and Harvard-Thorndike Laboratory, Beth Israel Deaconess Medical Center; and
{ddagger} Division of Rheumatology, Immunology and Allergy, Brigham and Women’s Hospital,
{dagger} Harvard Medical School, Boston, Massachusetts

Correspondence: Dr. Anne Nicholson-Weller, M.D., Dana 617, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215. E-mail: anichols{at}caregroup.harvard.edu

Isolated human polymorphonuclear neutrophils (PMN) responded to human C5a with an immediate, transient release of superoxide lasting from 0.5 to 5 min. This was followed by a second release of superoxide, which began at 10 min after addition of C5a, was sustained for more than 30 min, and required ICAM-1 immobilized in the wells. F(ab')2 monoclonal antibody (mAb) preparations were used to dissect the role of individual ß2 integrins and to avoid the confounding effects of ligating Fc receptors. Anti-CD18 mAb treatment of the PMN had no effect on the immediate first phase but completely inhibited the second, adhesion-dependent phase of superoxide production. Anti-CR3 mAb only inhibited the adhesion phase of superoxide production partially, implying that other ß2 integrins were involved. A mixture of anti-CD11a, anti-CD11b, and anti-CD11c was not able to block superoxide production completely, suggesting a role for {alpha}d/ß2. Surprisingly, blocking anti-LFA-1 mAb had no effect on superoxide production. Consistent with this observation, immobilized, purified ICAM-2, a specific counter-receptor for LFA-1, did not support the adhesion-dependent phase ofsuperoxide production. Thus, PMN treated with C5a used signals via CR3, P150/95, and {alpha}d/ß2, but not LFA-1, to support superoxide production. LFA-1 has been shown by others to mediate most of the adhesion necessary for transendothelial migration in vivo. The inability of LFA-1 ligation to stimulate superoxide production may be an important means of preventing blood-vessel damage when PMN migrate across the endothelium.

Key Words: human • complement • free radicals • inflammatory mediators




This article has been cited by other articles:


Home page
VASC ENDOVASCULAR SURGHome page
Hardev Ramandeep Singh Girn, S. Ahilathirunayagam, A. I. D. Mavor, and S. Homer-Vanniasinkam
Reperfusion Syndrome: Cellular Mechanisms of Microvascular Dysfunction and Potential Therapeutic Strategies
Vascular and Endovascular Surgery, September 1, 2007; 41(4): 277 - 293.
[Abstract] [PDF]


Home page
J. Immunol.Home page
L. K. Cherry, K. S. C. Weber, and L. B. Klickstein
A Dominant Jurkat T Cell Mutation That Inhibits LFA-1-Mediated Cell Adhesion Is Associated with Increased Cell Growth
J. Immunol., December 1, 2001; 167(11): 6171 - 6179.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the Society for Leukocyte Biology.